Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Go back to Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.26 +0.03 (2.44%)
Previous Close $1.23    52 Week High $6.22 
Open $1.23    52 Week Low $2.74 
Day High $1.29    P/E N/A 
Day Low $1.21    EPS $-0.21 
Volume 251,487